PHARMACISTS in the ACT are now authorised to administer medicines for injection, including Long-Acting Injectable Buprenorphine.
The Pharmaceutical Society of Australia's (PSA) ACT Branch President Olivia Collenette said, the "landmark change", which would enhance patient access to vital injectable medications, "came after a lot of campaigning".
"We have long championed the expansion of pharmacist scope of practice and, while there is still a long way to go, this is a significant step," she shared.
"We are thrilled that our advocacy on this particular issue has borne fruit, signalling a brighter future for pharmacy and reinforcing our commitment to advancing patient-centred care."
The PSA stated it has provided comprehensive training on administering medicines by injection.
The PSA added pharmacists are encouraged to access these resources to "ensure they are equipped with the necessary knowledge and skills to provide optimal care".
"PSA encourages all pharmacists in the ACT to familiarise themselves with the updated regulations and embrace this progressive expansion of their professional capabilities."
"By staying informed and ensuring adherence to best practices, pharmacists will continue to play a pivotal role in enhancing patient outcomes and promoting public health," Collenette concluded.
For more information CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jun 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jun 23
